Registration is now OPEN!
The PCMA Policy Forum takes place on April 25th at the International Spy Museum in Washington, D.C.
90% of prescriptions filled are for generic medications, and the average generic copay is $6.97.
In the past few years, some have been pushing the narrative that pharmacy benefit companies are driving independent pharmacies out of business. Their argument seems compelling, but is it true?
S. 127, the “Pharmacy Benefit Manager Transparency Act of 2023” fundamentally misconstrues the role of pharmacy benefit companies. . .
In the news
Prescription for Change - Improving Competition to Lower Drug Prices
For Your Information
OnYourRxSide is an educational platform that provides critical information to help you learn more about prescription drug pricing and understand PBMs’ role in advocating for lower prescription drug costs and greater savings on necessary medications.
Pharmacy Direct and Indirect Remuneration (DIR)
Value-based pharmacy reimbursement reduces drug costs for medicare beneficiaries and lowers spending. . .
The Value of PBMs
Pharmacy Benefit Managers (PBMs) are your advocates in the health care system, working to lower prescription drug costs for patients and payers.
High Priced Drugs
America’s PBMs are the only member of the prescription drug supply and payment chain working to reduce high drug costs, improve patient access, and increase affordability. . .
For America’s PBMs, our mission is simple: increase affordable access to prescription drugs for everyone.